Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update
Go back to Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update| (NASDAQ: ACHV) | Delayed: 7.84 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.84 | 52 Week High | $ | |||
| Open | $7.84 | 52 Week Low | $ | |||
| Day High | $7.84 | P/E | N/A | |||
| Day Low | $7.84 | EPS | $ | |||
| Volume | 5 | |||||

